CinderBio

CinderBio is pioneering the use of archaeal extremophilic enzymes to create revolutionary biocatalysts that operate under extreme conditions. The company's patented technology, born from a decade of research at Lawrence Berkeley National Laboratory, enables breakthroughs in proteomics by providing access to 20% more of the proteome than standard methods, facilitating applications like acute-care clinical diagnostics and novel biomarker discovery. Supported by multiple SBIR grants and accelerator programs, CinderBio is commercializing its platform across life sciences research, industrial cleaning, and biofuel production, positioning itself at the intersection of advanced biotechnology and sustainable industry.

Proprietary platform for discovering and producing ultra-stable, heat and acid-stable enzymes derived from archaeal extremophilic microbes found in volcanic environments, enabling novel proteomics workflows and robust industrial biocatalysis.

CinderBio competes with large proteomics reagent suppliers (e.g., Promega, Thermo Fisher) and industrial enzyme giants (e.g., Novozymes, DuPont). Its differentiation lies in the extreme stability and novel specificity of its archaeal enzymes, which enable applications and reveal biological insights not possible with conventional biocatalysts.